Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Performance of the Etest for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward Ceftazidime-Avibactam.

× No keyword cloud information.

2 in total

1. Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae.

Authors: David M Livermore; Shazad Mushtaq; Marina Warner; Jiancheng Zhang; Sunil Maharjan; Michel Doumith; Neil Woodford
Journal: Antimicrob Agents Chemother Date: 2010-11-01 Impact factor: 5.191

2. Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa.

Authors: Ryan K Shields; Cornelius J Clancy; A William Pasculle; Ellen G Press; Ghady Haidar; Binghua Hao; Liang Chen; Barry N Kreiswirth; M Hong Nguyen
Journal: J Clin Microbiol Date: 2018-01-24 Impact factor: 5.948

2 in total

7 in total

1. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex.

Authors: Sergio García-Fernández; Yohann Bala; Tom Armstrong; María García-Castillo; C A Burnham; Meghan A Wallace; Dwight Hardy; Gilles Zambardi; Rafael Cantón
Journal: J Clin Microbiol Date: 2020-01-28 Impact factor: 5.948

Review 2. Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing.

Authors: Paolo Gaibani; Tommaso Giani; Federica Bovo; Donatella Lombardo; Stefano Amadesi; Tiziana Lazzarotto; Marco Coppi; Gian Maria Rossolini; Simone Ambretti
Journal: Antibiotics (Basel) Date: 2022-05-06

3. German Multicenter Study Analyzing Antimicrobial Activity of Ceftazidime-Avibactam of Clinical Meropenem-Resistant Pseudomonas aeruginosa Isolates Using a Commercially Available Broth Microdilution Assay.

Authors: Jana Manzke; Raphael Stauf; Bernd Neumann; Ernst Molitor; Gunnar Hischebeth; Michaela Simon; Jonathan Jantsch; Jürgen Rödel; Sören L Becker; Alexander Halfmann; Thomas A Wichelhaus; Michael Hogardt; Annerose Serr; Christina Hess; Andreas F Wendel; Ekkehard Siegel; Holger Rohde; Stefan Zimmermann; Jörg Steinmann
Journal: Antibiotics (Basel) Date: 2022-04-19

4. Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China.

Authors: Qi Wang; Feifei Zhang; Zhanwei Wang; Hongbin Chen; Xiaojuan Wang; Yawei Zhang; Shuguang Li; Hui Wang
Journal: BMC Microbiol Date: 2020-06-29 Impact factor: 3.605

5. Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors: Maxwell J Lasko; Holly K Huse; David P Nicolau; Joseph L Kuti
Journal: Ann Clin Microbiol Antimicrob Date: 2021-01-19 Impact factor: 3.944

6. Comparative Evaluation of Vitek 2 and Etest versus Broth Microdilution for Ceftazidime/Avibactam and Ceftolozane/Tazobactam Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa.

Authors: Arhodoula Papadomanolaki; Maria Siopi; Polyxeni Karakosta; Sophia Vourli; Spyros Pournaras
Journal: Antibiotics (Basel) Date: 2022-06-27

7. Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods.

Authors: Venere Cortazzo; Brunella Posteraro; Giulia Menchinelli; Flora Marzia Liotti; Tiziana D'Inzeo; Barbara Fiori; Francesco Luzzaro; Maurizio Sanguinetti; Teresa Spanu
Journal: Antibiotics (Basel) Date: 2022-07-29

7 in total